In contrast, colo-rectal cancer specimens showed no clear patterning of TXNIP expression: TXNIP-positive tumors were detected in 34.5% of adenocarcinomas, 36.4% of high-grade adenomas, and some weak expression of 55.6% in low-grade adenomas (Figure 2f). This evidence concerns the gene TXNIP and rectal cancer.